{"pmid":32478445,"title":"Lung Ultrasound Can Influence the Clinical Treatment of Pregnant Women With COVID-19.","text":["Lung Ultrasound Can Influence the Clinical Treatment of Pregnant Women With COVID-19.","Lung ultrasound (LUS) is an effective tool to detect and monitor patients infected with 2019 coronavirus disease (COVID-19). The use of LUS on pregnant women is an emerging trend, considering its effectiveness during the outbreak. Eight pregnant women with a diagnosis of COVID-19 confirmed by nasal/throat real-time reverse transcription polymerase chain reaction testing who underwent point-of-care LUS examinations after routine obstetric ultrasound are described. A routinely performed LUS examination revealed serious lung involvement in 7 cases: 2 were initially asymptomatic; 3 have chest computed tomography; 1 had initial negative real-time reverse transcription polymerase chain reaction results; and 1 had initial negative computed tomographic findings. Treatment for COVID-19 was either commenced or changed in 87.5% of the patients (n = 7 of 8) on LUS findings. Among patients with abnormal LUS findings, treatment was commenced in 5 patients (71.5%) and changed in 2 patients (28.5%). One normal and 7 abnormal LUS cases indicate the impact of routine LUS on the clinical outcome and treatment of pregnant women.","J Ultrasound Med","Yassa, Murat","Birol, Pinar","Mutlu, Ali Memis","Tekin, Arzu Bilge","Sandal, Kemal","Tug, Niyazi","32478445"],"abstract":["Lung ultrasound (LUS) is an effective tool to detect and monitor patients infected with 2019 coronavirus disease (COVID-19). The use of LUS on pregnant women is an emerging trend, considering its effectiveness during the outbreak. Eight pregnant women with a diagnosis of COVID-19 confirmed by nasal/throat real-time reverse transcription polymerase chain reaction testing who underwent point-of-care LUS examinations after routine obstetric ultrasound are described. A routinely performed LUS examination revealed serious lung involvement in 7 cases: 2 were initially asymptomatic; 3 have chest computed tomography; 1 had initial negative real-time reverse transcription polymerase chain reaction results; and 1 had initial negative computed tomographic findings. Treatment for COVID-19 was either commenced or changed in 87.5% of the patients (n = 7 of 8) on LUS findings. Among patients with abnormal LUS findings, treatment was commenced in 5 patients (71.5%) and changed in 2 patients (28.5%). One normal and 7 abnormal LUS cases indicate the impact of routine LUS on the clinical outcome and treatment of pregnant women."],"journal":"J Ultrasound Med","authors":["Yassa, Murat","Birol, Pinar","Mutlu, Ali Memis","Tekin, Arzu Bilge","Sandal, Kemal","Tug, Niyazi"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478445","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jum.15367","keywords":["covid-19","lung ultrasound","pneumonia","pregnancy","severe acute respiratory syndrome novel coronavirus 2"],"topics":["Case Report"],"weight":1,"_version_":1668437835002150913,"score":9.490897,"similar":[{"pmid":32416318,"title":"Lung Ultrasound for Cardiologists in the Time of COVID-19.","text":["Lung Ultrasound for Cardiologists in the Time of COVID-19.","Lung ultrasound (LUS) is a point-of-care ultrasound (POCUS) technique used for its portability, widespread availability, and ability to provide real-time diagnostic information procedural guidance. LUS outperforms lung auscultation and chest X-ray, and is an alternative to chest computed tomography in select cases. Cardiologists may enhance their physical and echocardiographic examination with the addition of LUS. We present a practical guide to LUS, including device selection, scanning, findings, and interpretation. We outline a 3-point scanning protocol using 2D and M-mode imaging to evaluate the pleural line, pleural space, and parenchyma. We describe LUS findings and interpretation for common causes of respiratory failure. We provide guidance specific of COVID-19, which at the time of writing is responsible for a global pandemic. In this context, LUS emerges as a particularly useful tool for the diagnosis and management of patients with cardiopulmonary disease.","Can J Cardiol","Kiamanesh, Omid","Harper, Lea","Wiskar, Katie","Luksun, Warren","McDonald, Michael","Ross, Heather","Woo, Anna","Granton, John","32416318"],"abstract":["Lung ultrasound (LUS) is a point-of-care ultrasound (POCUS) technique used for its portability, widespread availability, and ability to provide real-time diagnostic information procedural guidance. LUS outperforms lung auscultation and chest X-ray, and is an alternative to chest computed tomography in select cases. Cardiologists may enhance their physical and echocardiographic examination with the addition of LUS. We present a practical guide to LUS, including device selection, scanning, findings, and interpretation. We outline a 3-point scanning protocol using 2D and M-mode imaging to evaluate the pleural line, pleural space, and parenchyma. We describe LUS findings and interpretation for common causes of respiratory failure. We provide guidance specific of COVID-19, which at the time of writing is responsible for a global pandemic. In this context, LUS emerges as a particularly useful tool for the diagnosis and management of patients with cardiopulmonary disease."],"journal":"Can J Cardiol","authors":["Kiamanesh, Omid","Harper, Lea","Wiskar, Katie","Luksun, Warren","McDonald, Michael","Ross, Heather","Woo, Anna","Granton, John"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416318","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cjca.2020.05.008","topics":["Diagnosis"],"weight":1,"_version_":1666994545948098563,"score":505.45453},{"pmid":32337795,"title":"Clinical role of lung ultrasound for the diagnosis and monitoring of COVID-19 pneumonia in pregnant women.","text":["Clinical role of lung ultrasound for the diagnosis and monitoring of COVID-19 pneumonia in pregnant women.","Lung ultrasound has recently been suggested by the Chinese Critical Care Ultrasound Study Group and Italian Academy of Thoracic Ultrasound as an accurate tool to detect lung involvement during COVID-19. Although chest Computer Tomography (CT) represents the gold standard to assess lung involvement, with a specificity even superior to the nasal/pharyngeal swab for diagnosis, lung ultrasound examination can be a valid alternative to CT scan, with some advantages, particularly desirable for pregnant women. Indeed, ultrasound can be performed directly at bed side by a single operator, reducing the risk of spreading the outbreak among health professionals, as well as it is a radiation free exam making to be easier monitoring those patients who require serial exams. In the present study, we reported four cases of pregnant women affectd by COVID-19 infection who have been monitoring with lung ultrasound examination. All patients showed ultrasound features indicative of COVID-19 pneumonia at admission: irregular pleural lines and vertical artifacts (B-lines) were observed in all four cases, whereas patchy areas of white lung in two cases. LUS was more sensitive than chest X-ray in detecting COVID-19. Three patients had resolution of lung pathology at ultrasound after 96 h of admission. Two pregnancies are ongoing, whereas two patients had cesarean delivery with no fetal complications. PCR testing of both cord blood and newborn swabs were negative in both cases. This article is protected by copyright. All rights reserved.","Ultrasound Obstet Gynecol","Buonsenso, D","Raffaelli, F","Tamburrini, E","Biasucci, D G","Salvi, S","Smargiassi, A","Inchingolo, R","Scambia, G","Lanzone, A","Testa, A C","Moro, F","32337795"],"abstract":["Lung ultrasound has recently been suggested by the Chinese Critical Care Ultrasound Study Group and Italian Academy of Thoracic Ultrasound as an accurate tool to detect lung involvement during COVID-19. Although chest Computer Tomography (CT) represents the gold standard to assess lung involvement, with a specificity even superior to the nasal/pharyngeal swab for diagnosis, lung ultrasound examination can be a valid alternative to CT scan, with some advantages, particularly desirable for pregnant women. Indeed, ultrasound can be performed directly at bed side by a single operator, reducing the risk of spreading the outbreak among health professionals, as well as it is a radiation free exam making to be easier monitoring those patients who require serial exams. In the present study, we reported four cases of pregnant women affectd by COVID-19 infection who have been monitoring with lung ultrasound examination. All patients showed ultrasound features indicative of COVID-19 pneumonia at admission: irregular pleural lines and vertical artifacts (B-lines) were observed in all four cases, whereas patchy areas of white lung in two cases. LUS was more sensitive than chest X-ray in detecting COVID-19. Three patients had resolution of lung pathology at ultrasound after 96 h of admission. Two pregnancies are ongoing, whereas two patients had cesarean delivery with no fetal complications. PCR testing of both cord blood and newborn swabs were negative in both cases. This article is protected by copyright. All rights reserved."],"journal":"Ultrasound Obstet Gynecol","authors":["Buonsenso, D","Raffaelli, F","Tamburrini, E","Biasucci, D G","Salvi, S","Smargiassi, A","Inchingolo, R","Scambia, G","Lanzone, A","Testa, A C","Moro, F"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32337795","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/uog.22055","keywords":["covid-19","pocus","lung ultrasound","pregnancy"],"topics":["Case Report"],"weight":1,"_version_":1666138494265720833,"score":483.871},{"pmid":32409232,"pmcid":"PMC7196401","title":"Lung Ultrasound in Children with COVID-19: Preliminary Findings.","text":["Lung Ultrasound in Children with COVID-19: Preliminary Findings.","Recent evidence indicates the usefulness of lung ultrasound (LUS) in detecting coronavirus disease 19 (COVID-19) pneumonia. However, no data are available on the use of LUS in children with COVID-19 pneumonia. In this report, we describe LUS features of 10 consecutively admitted children with COVID-19 in two tertiary-level pediatric hospitals in Rome. LUS revealed signs of lung involvement during COVID-19 infection. In particular, vertical artifacts (70%), pleural irregularities (60%), areas of white lung (10%) and subpleural consolidations (10%) were the main findings in patients with COVID-19. No cases of pleural effusions were found. According to our experience, the routine use of LUS in the evaluation of children with suspected or confirmed COVID-19, when performed by clinicians with documented experience in LUS, was useful in diagnosing and monitoring pediatric COVID-19 pneumonia, reducing unnecessary radiation/sedation in children and exposure of health care workers to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","Ultrasound Med Biol","Musolino, Anna Maria","Supino, Maria Chiara","Buonsenso, Danilo","Ferro, Valentina","Valentini, Piero","Magistrelli, Andrea","Lombardi, Mary Haywood","Romani, Lorenza","D'Argenio, Patrizia","Campana, Andrea","32409232"],"abstract":["Recent evidence indicates the usefulness of lung ultrasound (LUS) in detecting coronavirus disease 19 (COVID-19) pneumonia. However, no data are available on the use of LUS in children with COVID-19 pneumonia. In this report, we describe LUS features of 10 consecutively admitted children with COVID-19 in two tertiary-level pediatric hospitals in Rome. LUS revealed signs of lung involvement during COVID-19 infection. In particular, vertical artifacts (70%), pleural irregularities (60%), areas of white lung (10%) and subpleural consolidations (10%) were the main findings in patients with COVID-19. No cases of pleural effusions were found. According to our experience, the routine use of LUS in the evaluation of children with suspected or confirmed COVID-19, when performed by clinicians with documented experience in LUS, was useful in diagnosing and monitoring pediatric COVID-19 pneumonia, reducing unnecessary radiation/sedation in children and exposure of health care workers to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."],"journal":"Ultrasound Med Biol","authors":["Musolino, Anna Maria","Supino, Maria Chiara","Buonsenso, Danilo","Ferro, Valentina","Valentini, Piero","Magistrelli, Andrea","Lombardi, Mary Haywood","Romani, Lorenza","D'Argenio, Patrizia","Campana, Andrea"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409232","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ultrasmedbio.2020.04.026","keywords":["children","coronavirus disease 19 (covid-19)","lung ultrasound","severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"],"locations":["Rome"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666989866135584769,"score":483.33994},{"pmid":32504135,"title":"Point-of-care lung ultrasound in three neonates with COVID-19.","text":["Point-of-care lung ultrasound in three neonates with COVID-19.","Since March 2020, the world is involved in the COVID-19 pandemic, a disease caused by a novel virus called SARS-CoV-2. Some authors have described the ultrasonographic findings of COVID-19 pneumonia in adults and children, but data on neonates are lacking. Our objective was to describe the ultrasonographic lung pattern on newborns with SARS-CoV-2 infection during the COVID-19 pandemic. Newborns who tested positive for SARS-CoV-2 PCR in respiratory samples and were evaluated with point-of-care lung ultrasound (LU) from March to April 2020 were included. LU was performed bedside by a single investigator at the time of diagnosis and every 48 h during the first week following diagnosis. Six areas were studied. Three neonates were included. Infants' comorbidities included meconium aspiration syndrome, bronchopulmonary dysplasia, and Hirschsprung's disease. One required mechanical ventilation. No deaths occurred. LU showed B-lines, consolidation, and spared areas. No pneumothorax or pleural effusion was observedConclusions: LU could be of value when managing COVID-19 neonates. We describe the findings of lung ultrasound monitoring during the first week following diagnosis in three neonates with SARS-CoV-2 infection.What is known:* Lung ultrasound (LU) is a useful tool in COVID-19 management in adults. To date, no report on LU and neonates with SARS-CoV-2 infection has been published.What is new:* This study adds evidence about LU findings in neonates with SARS-CoV-2 infection.","Eur J Pediatr","Gregorio-Hernandez, R","Escobar-Izquierdo, A B","Cobas-Pazos, J","Martinez-Gimeno, A","32504135"],"abstract":["Since March 2020, the world is involved in the COVID-19 pandemic, a disease caused by a novel virus called SARS-CoV-2. Some authors have described the ultrasonographic findings of COVID-19 pneumonia in adults and children, but data on neonates are lacking. Our objective was to describe the ultrasonographic lung pattern on newborns with SARS-CoV-2 infection during the COVID-19 pandemic. Newborns who tested positive for SARS-CoV-2 PCR in respiratory samples and were evaluated with point-of-care lung ultrasound (LU) from March to April 2020 were included. LU was performed bedside by a single investigator at the time of diagnosis and every 48 h during the first week following diagnosis. Six areas were studied. Three neonates were included. Infants' comorbidities included meconium aspiration syndrome, bronchopulmonary dysplasia, and Hirschsprung's disease. One required mechanical ventilation. No deaths occurred. LU showed B-lines, consolidation, and spared areas. No pneumothorax or pleural effusion was observedConclusions: LU could be of value when managing COVID-19 neonates. We describe the findings of lung ultrasound monitoring during the first week following diagnosis in three neonates with SARS-CoV-2 infection.What is known:* Lung ultrasound (LU) is a useful tool in COVID-19 management in adults. To date, no report on LU and neonates with SARS-CoV-2 infection has been published.What is new:* This study adds evidence about LU findings in neonates with SARS-CoV-2 infection."],"journal":"Eur J Pediatr","authors":["Gregorio-Hernandez, R","Escobar-Izquierdo, A B","Cobas-Pazos, J","Martinez-Gimeno, A"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504135","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s00431-020-03706-4","keywords":["covid-19","coronavirus","lung ultrasound","neonate","point-of-care ultrasound","sars-cov-2","ultrasonography"],"topics":["Diagnosis"],"weight":1,"_version_":1668892488167849984,"score":477.211},{"pmid":32398268,"title":"Lung ultrasound in the monitoring of COVID-19 infection.","text":["Lung ultrasound in the monitoring of COVID-19 infection.","INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a highly contagious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pneumonia and acute respiratory distress syndrome (ARDS) are the most common severe complications. There is growing evidence regarding the imaging findings of COVID-19 in chest X-rays and computed tomography (CT) scans; however, their availability to clinical staff in this pandemic outbreak might be compromised. At this moment, the role of lung ultrasound (LUS) has yet to be explored. The purpose of this case report is to describe the natural course of the disease in mild infection managed at home. CASE REPORT: We report a 35-year-old man with recently diagnosed COVID-19 infection. Clinical examination was unremarkable. The diagnosis of mild disease was made clinically which was later reaffirmed by LUS after identifying a bilateral small pleural effusion and a thickened pleural line. During follow up, subpleural consolidations appeared before symptoms slightly aggravated (cough, tiredness and fever). The patient's condition improved after adjustment of therapy at home. CONCLUSION: LUS is an excellent tool in the characterisation of COVID-19 infection and is more available than CT or X-ray. We emphasise the utility and the opportunity that LUS presents in some clinical scenarios, like this COVID-19 pandemic, and how it may serve as a monitoring and therapy guide.","Clin Med (Lond)","Tung-Chen, Yale","32398268"],"abstract":["INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a highly contagious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pneumonia and acute respiratory distress syndrome (ARDS) are the most common severe complications. There is growing evidence regarding the imaging findings of COVID-19 in chest X-rays and computed tomography (CT) scans; however, their availability to clinical staff in this pandemic outbreak might be compromised. At this moment, the role of lung ultrasound (LUS) has yet to be explored. The purpose of this case report is to describe the natural course of the disease in mild infection managed at home. CASE REPORT: We report a 35-year-old man with recently diagnosed COVID-19 infection. Clinical examination was unremarkable. The diagnosis of mild disease was made clinically which was later reaffirmed by LUS after identifying a bilateral small pleural effusion and a thickened pleural line. During follow up, subpleural consolidations appeared before symptoms slightly aggravated (cough, tiredness and fever). The patient's condition improved after adjustment of therapy at home. CONCLUSION: LUS is an excellent tool in the characterisation of COVID-19 infection and is more available than CT or X-ray. We emphasise the utility and the opportunity that LUS presents in some clinical scenarios, like this COVID-19 pandemic, and how it may serve as a monitoring and therapy guide."],"journal":"Clin Med (Lond)","authors":["Tung-Chen, Yale"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32398268","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.7861/clinmed.2020-0123","keywords":["covid-19","sars-cov-2","lung ultrasound"],"topics":["Case Report"],"weight":1,"_version_":1666865855056576512,"score":468.66098}]}